Annexin A5 may also be used as a biomarker in the study of diseases, such as tumours and asthma, and may promote the occurrence and development of laryngeal cancer and nasopharyngeal carcinoma (Zhang, Meng & Jing, 2022). This evidence concerns the gene ANXA5 and laryngeal carcinoma.